1010552008: Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorised by disposition\Hepatitis C virus protein NS5B inhibitor-containing product\Sofosbuvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir and velpatasvir only product\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by disposition\Hepatitis C virus protein NS5B inhibitor-containing product\Sofosbuvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by disposition\Hepatitis C virus protein NS5B inhibitor-containing product\Sofosbuvir-containing product\Sofosbuvir-containing product in oral dose form\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by disposition\Hepatitis C virus protein NS5A inhibitor-containing product\Velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir and velpatasvir only product\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by disposition\Hepatitis C virus protein NS5A inhibitor-containing product\Velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Nucleotidyltransferase inhibitor-containing product\RNA polymerase inhibitor-containing product\Sofosbuvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir and velpatasvir only product\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Nucleotidyltransferase inhibitor-containing product\RNA polymerase inhibitor-containing product\Sofosbuvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Nucleotidyltransferase inhibitor-containing product\RNA polymerase inhibitor-containing product\Sofosbuvir-containing product\Sofosbuvir-containing product in oral dose form\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet

\Medicinal product categorised by structure\Ether structure-containing product\Velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir and velpatasvir only product\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by structure\Ether structure-containing product\Velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Sofosbuvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir and velpatasvir only product\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Sofosbuvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Sofosbuvir-containing product\Sofosbuvir-containing product in oral dose form\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Azole-containing product\Imidazole-containing product\Velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir and velpatasvir only product\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Azole-containing product\Imidazole-containing product\Velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet

\Medicinal product categorised by therapeutic role\Antiviral agent\...

\Velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product\...

\Sofosbuvir and velpatasvir only product\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet

\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet

\Sofosbuvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir and velpatasvir only product\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Sofosbuvir-containing product\Sofosbuvir- and velpatasvir-containing product\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet
\Sofosbuvir-containing product\Sofosbuvir-containing product in oral dose form\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet

\Product manufactured as oral dose form\Sofosbuvir-containing product in oral dose form\Sofosbuvir- and velpatasvir-containing product in oral dose form\Sofosbuvir and velpatasvir only product in oral dose form\Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet

Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4213155010 Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core

4213156011 Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet en Synonym Active Case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Plays role	Antiviral therapeutic role	true	Inferred relationship	Some
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has unit of presentation	Tablet	true	Inferred relationship	Some
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Some
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Some
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Is a	Sofosbuvir and velpatasvir only product in oral dose form	true	Inferred relationship	Some
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has presentation strength numerator unit	mg	true	Inferred relationship	Some	1
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Some	1
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	1
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has presentation strength numerator value	400	false	Inferred relationship	Some	1
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has BoSS	Sofosbuvir	true	Inferred relationship	Some	1
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has precise active ingredient	Sofosbuvir	true	Inferred relationship	Some	1
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has precise active ingredient	Velpatasvir	true	Inferred relationship	Some	2
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has BoSS	Velpatasvir	true	Inferred relationship	Some	2
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	2
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has presentation strength numerator unit	mg	true	Inferred relationship	Some	2
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Some	2
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	Has presentation strength numerator value	100	false	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4213155010	Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
4213156011	Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet	en	Synonym	Active	Case insensitive	SNOMED CT core